Medical Device

Natus Medical (NASDAQ:BABY) today announced financial results for the three months and full year ended March 31, 2018. As quoted in the press release: For the first quarter ended March 31, 2018, the Company reported revenue of $128.6 million, an increase of 3.1% compared to $124.7 million reported for the first quarter 2017. Revenue for the first quarter …

Natus Medical (NASDAQ:BABY) today announced financial results for the three months and full year ended March 31, 2018.

As quoted in the press release:

For the first quarter ended March 31, 2018, the Company reported revenue of $128.6 million, an increase of 3.1% compared to $124.7 million reported for the first quarter 2017. Revenue for the first quarter of 2017 included $9.0 million from our contract with the government of Venezuela which did not reoccur in 2018. GAAP gross profit margin was 55.7% vs. 53.5% in the first quarter 2017. GAAP net loss was $3.1 million, or $0.10 per share, compared with GAAP net income of $0.3 million, or $0.01 per diluted share in the first quarter 2017.

Non-GAAP earnings per diluted share was $0.24 for the first quarter 2018, compared to $0.30 in the first quarter 2017. Non-GAAP net income was $8.0 million for the first quarter 2018 compared to the prior year’s first quarter non-GAAP net income of $9.8 million. Non-GAAP gross profit margin was 59.0% vs. 57.8% reported for the first quarter of 2017.

The Company repurchased $4.7 million of its stock and repaid $25.0 million of outstanding debt during the first quarter of 2018.

Click here to read the full press release.

MARKETS

Markets
TSX20179.81+187.93
TSXV680.49+7.47
DOW33761.05+424.38
S&P 5004280.15+72.88
NASD13047.19+267.27
ASX7032.50-38.50

COMMODITIES

Commodities
Gold1801.89+0.36
Silver20.82+0.02
Copper3.68-0.03
Palladium2224.19+14.20
Platinum965.47+2.48
Oil91.88-2.46
Heating Oil3.51+0.03
Natural Gas8.78-0.09

DOWNLOAD FREE REPORTS

×